JP Morgan Chase’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

JP Morgan Chase’s Portfolio LMNL Stock Details LMNL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Hold	0	–	–	–	7408
2022 Q4	–	Hold	0	–	–	–	7195
2022 Q3	–	Hold	0	–	–	–	7020
2022 Q2	–	Hold	0	–	–	–	7055
2022 Q1	–	Hold	0	–	–	–	7166
2021 Q4	–	Hold	0	–	–	–	7097
2021 Q3	–	Sell	-5	Closed	-$144	–	6934
2021 Q2	$0	Buy	+5	New	+$218	﹤0.01%	6704
2021 Q1	–	Hold	0	–	–	–	6459
2020 Q4	–	Sell	-309	Closed	-$16.9K	–	6034
2020 Q3	$32K	Buy	+309	New	+$41.8K	﹤0.01%	5067
2020 Q2	–	Sell	-245	Closed	-$16K	–	5795
2020 Q1	$16K	Buy	245 +30	+14%	+$2.71K	﹤0.01%	4992
2019 Q4	$18K	Buy	+215	New	+$14.5K	﹤0.01%	5333

Other funds holding LMNL

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

ECM

Estabrook Capital Management New York $685M AUM 26.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

JP Morgan Chase's LMNL Position: Q1 2023 in Review

JP Morgan Chase held its Liminal BioSciences Inc. Common Shares (LMNL) position steady in Q1 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7408.

JP Morgan Chase first reported a position in LMNL in Q4 2019 and has held it in 4 quarters since. The position peaked at $32K in Q3 2020. 8 funds tracked by Wall St. Rank hold LMNL as of Q1 2023.

JP Morgan Chase held 0 shares of Liminal BioSciences Inc. Common Shares worth $0 as of Q1 2023.
JP Morgan Chase left its Liminal BioSciences Inc. Common Shares share count unchanged in Q1 2023.
Liminal BioSciences Inc. Common Shares made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2023, its #7408 holding.
JP Morgan Chase first reported a position in Liminal BioSciences Inc. Common Shares in Q4 2019 and has held it in 4 quarters since.
JP Morgan Chase's Liminal BioSciences Inc. Common Shares position peaked at $32K in Q3 2020.
8 funds tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q1 2023.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.